Patent · US Active

Atropine pharmaceutical compositions

US11730727B2 · kind B2 · utility

0Cited by
11References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 31, 2020
Grant dateAug 22, 2023
Priority date—
Expiry dateAug 31, 2040

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P27/10
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The inventive subject matter is directed to compositions and methods for sterile and storage stable low-dose atropine formulations with improved stability. Most preferably, the compositions presented herein are substantially preservative free and exhibit less than 0.35% tropic acid from degradation of atropine. Advantageously, contemplated formulations are also substantially free of preservatives.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.